Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve To consider ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.5 pts more than Nifty Microcap 250 and 5.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Welcure Drugs & Pharmaceuticals has called a board meeting for 14 May 2025. The main items on the agenda are: (1) the appointment of Mr. Chintan Didawala Ganpat (DIN: 11088268) as Managing Director — he is currently already a Director on the board and has signed this very intimation; (2) an alteration in the Main Objects Clause of the Memorandum of Association to add new business objects; and (3) an increase in the Authorized Share Capital of the company. The board will also approve a Postal Ballot process (via e-voting) to seek shareholder approval for these items, and appoint Mrs. Vishakha Agrawal as Scrutinizer for the postal ballot.
The elevation of an existing Director to Managing Director suggests a planned leadership transition at the top. The proposed increase in authorized share capital and addition of new objects to the MoA hint at possible future fundraising and business diversification, which shareholders will vote on via postal ballot.